ScoreWhy is Dr Agarwals Eye Hospital Ltd ?
1
Healthy long term growth as Operating profit has grown by an annual rate 54.61%
2
The company has declared Positive results for the last 5 consecutive quarters
- PAT(Latest six months) At Rs 33.52 cr has Grown at 27.02%
- DEBT-EQUITY RATIO(HY) Lowest at 0.94 times
- OPERATING PROFIT TO INTEREST(Q) Highest at 17.21 times
3
With ROCE of 17.3, it has a Fair valuation with a 4.5 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 14.23%, its profits have risen by 28.3% ; the PEG ratio of the company is 1.4
4
29.26% of Promoter Shares are Pledged
- In falling markets, high promoter pledged shares puts additional downward pressure on the stock prices
5
Consistent Returns over the last 3 years
- Along with generating 14.23% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Dr Agarwal's Eye should be less than 10%
- Overall Portfolio exposure to Hospital should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Hospital)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Dr Agarwal's Eye for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Dr Agarwal's Eye
14.23%
0.47
30.41%
Sensex
-6.4%
-0.49
12.94%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
27.49%
EBIT Growth (5y)
54.61%
EBIT to Interest (avg)
7.44
Debt to EBITDA (avg)
2.77
Net Debt to Equity (avg)
0.67
Sales to Capital Employed (avg)
0.82
Tax Ratio
25.11%
Dividend Payout Ratio
5.16%
Pledged Shares
29.26%
Institutional Holding
4.33%
ROCE (avg)
14.56%
ROE (avg)
27.84%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
34
Industry P/E
62
Price to Book Value
6.89
EV to EBIT
26.24
EV to EBITDA
18.00
EV to Capital Employed
4.54
EV to Sales
5.55
PEG Ratio
1.37
Dividend Yield
0.13%
ROCE (Latest)
17.28%
ROE (Latest)
20.24%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend12What is working for the Company
PAT(Latest six months)
At Rs 33.52 cr has Grown at 27.02%
DEBT-EQUITY RATIO(HY)
Lowest at 0.94 times
OPERATING PROFIT TO INTEREST(Q)
Highest at 17.21 times
NET SALES(Q)
Highest at Rs 120.01 cr
-2What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 6.71 cr
EPS(Q)
Lowest at Rs 33.62
Loading Valuation Snapshot...
Here's what is working for Dr Agarwal's Eye
Operating Profit to Interest - Quarterly
Highest at 17.21 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Profit After Tax (PAT) - Latest six months
At Rs 33.52 cr has Grown at 27.02%
Year on Year (YoY)MOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Debt-Equity Ratio - Half Yearly
Lowest at 0.94 times and Fallen
each half year in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Net Sales - Quarterly
Highest at Rs 120.01 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 120.01 cr has Grown at 20.21%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for Dr Agarwal's Eye
Earnings per Share (EPS) - Quarterly
Lowest at Rs 33.62
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 6.71 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
